Tuesday May 22 | Patch.com
StemCells, Inc. Announces Positive Spinal Cord Injury Trial Results
The following is a press release issued by StemCells, Inc .: NEWARK, CA - StemCells, Inc.
Tuesday May 22 | Seeking Alpha
Stem Cell Hype Has Yet To Breed Profits
Over the past few years, stem cell therapies have emerged as an intriguing new frontier in biotechnology research as scientists have begun exploring ways to monetize stem cells' unique plasticity.
StemCells, Inc. Reports Positive Interim Safety Data From Spinal Cord Injury Trial
NEWARK, Calif., May 17, 2012 -- StemCells, Inc. today announced completion of the first planned interim safety review of the Company's Phase I/II spinal cord injury clinical trial, which indicated that the surgery, immunosuppression and the cell transplants have been well-tolerated. The trial, which is designed to evaluate the safety and ... (more)
StemCells, Inc. to Provide Progress Report on Spinal Cord Injury...
StemCells, Inc. today announced that Armin Curt, MD, FRCPC, Professor and Chairman, Spinal Cord Injury Center at the University of Zurich, and Medical Director of the Paraplegic Center at the Balgrist University Hospital and principal investigator for the Company's Phase I/II clinical trial in chronic spinal cord injury, will provide a progress ... (more)